74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Waters Corp
Closed
Sector Healthcare
373.8 -1.91
Overview
Share price change
24h
Min
371.74
Max
376.54
Income | 70M 231M |
|---|---|
Sales | 133M 873M |
P/E Sector Avg | 35.258 73.394 |
EPS | 4.1 |
Profit margin | 26.515 |
Employees | 7,600 |
EBITDA | 30M 292M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +9.41 upside |
Next Earnings | 6 May 2025 |
|---|
Market Cap | -2.2B 22B |
|---|---|
Previous open | 375.71 |
Previous close | 373.8 |
News Sentiment
By Acuity
22%
78%
35 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
Waters Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Waters Corp Forecast
Price Target
By TipRanks
9.41% upside
12 Months Forecast
Average 410.08 USD 9.41%
High 450 USD
Low 360 USD
Based on 12 Wall Street analysts offering 12 month price targets forWaters Corp - Dist in the last 3 months.
Sentiment
By Acuity
35 / 393 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Waters Corp
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
